Abbott Laboratories Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
07/31

DJ Abbott Laboratories Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Abbott Laboratories $(ABT)$ slid 2.21% to $105.61 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.66% to 7,437.63 and the Dow Jones Industrial Average rising 1.19% to 52,208.06.

The stock's fall snapped a six-day winning streak.

Abbott Laboratories closed 23.19% short of its 52-week high of $137.49, which the company reached on September 22nd.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 3.66% to $255.82, Pfizer Inc. $(PFE)$ fell 0.95% to $24.91, and Merck & Co. Inc. $(MRK)$ fell 0.44% to $129.79.

Trading volume (8.1 M) remained 5.0 million below its 50-day average volume of 13.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 30, 2026.

 

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10